THNR:NYE-Amplify ETF Trust (USD)

ETF | Others |

Last Closing

USD 23.1098

Change

-0.01 (-0.05)%

Market Cap

USD 4.36M

Volume

2.00K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.15 (-0.79%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.43 (+0.74%)

USD 37.61B
DFAC Dimensional U.S. Core Equity 2..

+0.30 (+0.86%)

USD 33.40B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 28.50B
JPST JPMorgan Ultra-Short Income ET..

+0.01 (+0.02%)

USD 28.13B
DTB DTE Energy Company 2020 Series

-0.19 (-0.99%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

+4.74 (+6.43%)

USD 21.47B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 16.06B
AVUV Avantis® U.S. Small Cap Value..

+0.99 (+1.03%)

USD 15.95B
DFUS Dimensional U.S. Equity ETF

+0.69 (+1.07%)

USD 13.15B

ETFs Containing THNR

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 4.36M 8% B- 3% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.